Request Trial
shutterstock_1826152037_lev_radin
Lev Radin / Shutterstock.com
23 November 2023PharmaMarisa Woutersen

UPC judge and Regeneron counsel urge lobbying to improve court's transparency

Judge encourages lawyers and public to make their voices heard over transparency concerns | Awkward access to public hearings ‘causing problems’ says Regeneron counsel | Plea for public virtual hearings as judge notes that requests have been ‘coming in by the dozen’ | Panellists discuss at LSPN Europe.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
Vanda revives challenge over braille-free label on generic sleep disorder drug
19 August 2026   Questions over braille on a generic sleep disorder drug label will face fresh scrutiny after an appeals court found fault with the FDA’s approach.
Pharma
Novartis scores UK win in high-stakes Entresto fight
14 August 2026   Pressure for generic manufacturers of the blockbuster heart drug Entresto is mounting as the Swiss pharma company secures a win over a challenge to its UK patent protection.
Pharma
Lilly mounts defence as generics circle Mounjaro and Zepbound
11 August 2026   A litigation campaign against generic drugmakers, including Sandoz, Hikma, and Amenal, raise the stakes in the fight over two of the world’s most lucrative weight loss and diabetes treatments.


Editor's picks

Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

Editor's picks

Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026

More features

Vanda revives challenge over braille-free label on generic sleep disorder drug
Abbott fends off Chinese rival’s patent challenge at UPC
Former head of litigation at Nokia returns to Bird & Bird
Former USPTO acting director takes the helm at C4IP
Europe’s missing biotech bridge: Why IP ownership matters more than capital access
Novartis scores UK win in high-stakes Entresto fight
Invisalign maker secures first China win against clear aligner rival
Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie